Transhepatic Therapies for Metastatic Uveal Melanoma

被引：33
|
作者：
Eschelman, David J. [1 ,2 ,3 ]
Gonsalves, Carin F. [1 ,2 ,3 ]
Sato, Takami [4 ]
机构：
[1] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA
[2] Kimmel Canc Ctr, Div Intervent Radiol, Philadelphia, PA USA
[3] Kimmel Canc Ctr, Dept Radiol, Philadelphia, PA USA
[4] Kimmel Canc Ctr, Dept Med Oncol, Philadelphia, PA USA
来源：
SEMINARS IN INTERVENTIONAL RADIOLOGY | 2013年 / 30卷 / 01期
关键词：
uveal melanoma; liver metastases; chemoembolization; immunoembolization; radioembolization; HEPATIC ARTERIAL CHEMOEMBOLIZATION; OCULAR MELANOMA; LIVER METASTASES; TRANSARTERIAL IMMUNOEMBOLIZATION; HEPATOCELLULAR-CARCINOMA; MONOSOMY; SURVIVAL; EXPERIENCE; TUMORS; RADIOEMBOLIZATION;
D O I：
10.1055/s-0033-1333652
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Despite successful treatment of the primary tumor, uveal melanoma has a propensity to metastasize to the liver. Prognosis is poor due to the very aggressive nature of these tumors. Because systemic therapies are relatively ineffective and patient survival correlates to disease control in the liver, locoregional therapies provide a means of prolonging survival. We review various techniques including chemoembolization, immunoembolization, radioembolization, arterial fotemustine infusion, and hepatic perfusion for the treatment of liver metastases from uveal melanoma.
引用
收藏
页码：39 / 48
页数：10
相关论文
共 50 条
  • [31] Clinical Trials in Metastatic Uveal Melanoma: Immunotherapy
    Orloff, Marlana
    OCULAR ONCOLOGY AND PATHOLOGY, 2021, 7 (03) : 168 - 176
  • [32] Long Term Survival in Metastatic Uveal Melanoma
    Buzzacco, D. M.
    Cebulla, C.
    Olencki, T.
    Abdel-Rahman, M. H.
    Davidoff, F. H.
    Kendra, K.
    Craven, A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [33] Multiregional genetic evolution of metastatic uveal melanoma
    Daniel A. Rodriguez
    Jessica Yang
    Michael A. Durante
    Alexander N. Shoushtari
    Stergios J. Moschos
    Kazimierz O. Wrzeszczynski
    J. William Harbour
    Richard D. Carvajal
    npj Genomic Medicine, 6
  • [34] Serum markers to detect metastatic uveal melanoma
    Barak, Vivian
    Frenkel, Shachar
    Kalickman, Inna
    Maniotis, Andrew J.
    Folberg, Robert
    Peter, Jacob
    ANTICANCER RESEARCH, 2007, 27 (4A) : 1897 - 1900
  • [35] Treatment of metastatic uveal melanoma with intravenous fotemustine
    Spagnolo, Francesco
    Grosso, Marco
    Picasso, Virginia
    Tornari, Elena
    Pesce, Marianna
    Queirolo, Paola
    MELANOMA RESEARCH, 2013, 23 (03) : 196 - 198
  • [36] Inflammatory cell infiltrates in metastatic uveal melanoma
    Krishna, Y.
    McCarthy, C.
    Kalirai, H.
    Coupland, S.
    ACTA OPHTHALMOLOGICA, 2016, 94
  • [37] Novel treatment paradigms for metastatic uveal melanoma
    Sapna P. Patel
    Steven C. Katz
    Cancer Gene Therapy, 2022, 29 : 1807 - 1808
  • [38] Gangliosides in human uveal melanoma metastatic process
    Tardif, M
    Coulombe, J
    Soulieres, D
    Rousseau, AP
    Pelletier, G
    INTERNATIONAL JOURNAL OF CANCER, 1996, 68 (01) : 97 - 101
  • [39] Clinical Activity of Ipilimumab for Metastatic Uveal Melanoma
    Luke, Jason J.
    Callahan, Margaret K.
    Postow, Michael A.
    Romano, Emanuela
    Ramaiya, Nikhil
    Bluth, Mark
    Giobbie-Hurder, Anita
    Lawrence, Donald P.
    Ibrahim, Nageatte
    Ott, Patrick A.
    Flaherty, Keith T.
    Sullivan, Ryan J.
    Harding, James J.
    D'Angelo, Sandra
    Dickson, Mark
    Schwartz, Gary K.
    Chapman, Paul B.
    Wolchok, Jedd D.
    Hodi, F. Stephen
    Carvajal, Richard D.
    CANCER, 2013, 119 (20) : 3687 - 3695
  • [40] Liver fibrosis and metastatic uveal melanoma (mUM)
    Coupland, Sarah E.
    Prendergast, Samuel
    Ahmed, Ibrar
    Sakai, Takao
    Kalirai, Helen
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
12345